Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04737941
Other study ID # 3/2021
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 26, 2021
Est. completion date March 1, 2026

Study information

Verified date March 2021
Source Oulu University Hospital
Contact Matti Pokela, Docent
Phone 083152011
Email matti.pokela@ppshp.fi
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This multicenter randomized controlled trial compares immediate foam sclerotherapy vs. scheduled endovenous treatment in patients with venous ulceration.


Description:

To evaluate the effect of first-visit foam sclerotherapy, patients with venous ulcer are randomly assigned to first-visit foam sclerotherapy- or to scheduled treatment group. The primary outcome for this study is time to ulcer healing. For this study, based on Oulu University Hospital's retrospective data (partly published in Pihlaja et al 2020) of venous ulcer healing the investigators assumed Hazard Ratio 1.5 for venous ulcer to heal in first-visit foam sclerotherapy group compared to scheduled treatment group. Assuming drop-out of 10% this study recruits total of 248 patients (a=0.05, b=0.2). For the primary outcome the follow-up time is one year. In both groups endothermal ablation and/or foam sclerotherapy are used to treat the ulcer-related insufficient veins and truncal insufficiency. Class 2 thigh-high compression, or best possible compression therapy patient tolerates is facilitated in both groups


Recruitment information / eligibility

Status Recruiting
Enrollment 248
Est. completion date March 1, 2026
Est. primary completion date March 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient informed consent - Venous ulcer, aged from one month to one year - Duplex ultrasonography verified (vein reflux greater than >0.5 second) superficial venous insufficiency - Sufficient arterial circulation (at least on criterion met: Palpable distal pulses / ankle-brachial index > 0,8 / Toe pressure >60mmhg) Exclusion Criteria: - Leg ulcers other than venous etiology - Ulcers requiring operation theater revision - Patent foramen ovale - Several times recurrent (over 3 recurrences) venous ulcer - Body Mass Index over 40 - Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Endothermal Ablation
Endothermal ablation is performed to suitable insufficient truncal veins (Great-, Anterior Accessory- and/or Small Saphenous Vein)
Foam Sclerotherapy
Foam sclerotherapy is performed to insufficient veins distal to the truncal superficial veins.

Locations

Country Name City State
Finland Helsinki University Central Hospital Helsinki
Finland Kuopio University Hospital Kuopio
Finland Paijat-Hame Central Hospital Lahti
Finland Oulu University Hospital Oulu
Finland Satakunta Central Hospital Pori
Finland Tampere University Hospital Tampere
Finland Turku University Hospital Turku
Finland Vaasa Central Hospital Vaasa

Sponsors (2)

Lead Sponsor Collaborator
Oulu University Hospital Helsinki University Central Hospital

Country where clinical trial is conducted

Finland, 

References & Publications (1)

Pihlaja T, Torro P, Ohtonen P, Romsi P, Pokela M. Ten years of experience with first-visit foam sclerotherapy to initiate venous ulcer healing. J Vasc Surg Venous Lymphat Disord. 2020 Nov 25. pii: S2213-333X(20)30638-7. doi: 10.1016/j.jvsv.2020.11.012. [Epub ahead of print] — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Time to ulcer Healing Complete re-epithelialisation of ulcer area 0-365 days
Secondary EQ-5D Questionnaire Score 0-100 where higher is better 0-365 days
Secondary Wound-QOL Questionnaire Score 0-17 where lower is better 0-365 days
Secondary Venous ulcer area Reduction on venous ulcer maximum diameter 0-365 days
See also
  Status Clinical Trial Phase
Recruiting NCT05633277 - Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections N/A
Recruiting NCT02838784 - Efficacy and Safety of Artacentâ„¢ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers N/A
Completed NCT02092870 - Adipose Derived Regenerative Cellular Therapy of Chronic Wounds Phase 2
Terminated NCT00847002 - Flexitouch Treatment for Venous Ulcers N/A
Completed NCT01858272 - Preliminary Testing of New Treatment for Chronic Leg Wounds Phase 1
Not yet recruiting NCT05877378 - Efficacy of PICO Single-use System in Chronic Ulcers N/A
Recruiting NCT05409976 - The GORE® VIAFORT Vascular Stent IVC Study N/A
Terminated NCT01396304 - Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers Phase 4
Not yet recruiting NCT06007703 - Evaluation of the Efficacy of Multilayer Compression & UrgoStart Plus
Completed NCT04046120 - Comparison of the Effectiveness of Two Medical Compression Bandage Application Techniques by Measuring Interface Pressures Depending on Whether or Not the Heel is Included in Patients With Open Venous Ulcers N/A
Terminated NCT04021316 - Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration N/A
Completed NCT05729334 - Clinical Investigation EUCLIDES-01 for the Calculation of the Area of Skin Lesions N/A
Completed NCT03070938 - PuraPlyâ„¢ Antimicrobial Wound Matrix and Wound Management N/A
Terminated NCT01853384 - Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers Phase 3
Completed NCT00558662 - Randomized Clinical Trial (RCT) to Compare the Efficacy of Coban 2 Versus SSB in the Treatment of Venous Leg Ulcers N/A
Completed NCT01750749 - Cell Therapy for Venous Leg Ulcers Pilot Study Phase 1
Completed NCT01327937 - A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers Phase 4
Completed NCT00820196 - A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study) Phase 2
Completed NCT00301496 - Randomized Controlled 8-Week Crossover Evaluation of Compression Bandage Systems for Venous Leg Ulcers N/A
Recruiting NCT05489588 - The GORE® VIAFORT Vascular Stent Iliofemoral Study N/A